[Therapeutic prospects with chemo-antibiotic association in bacterial-protozoan diseases of the intestine].
D000284:Administration, Oral; D000818:Animals; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D003967:Diarrhea / Q000188:drug therapy* / Q000209:etiology; D004341:Drug Evaluation; D004357:Drug Synergism; D004404:Dysentery, Amebic / Q000188:drug therapy; D051379:Mice; D010303:Paromomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D011528:Protozoan Infections / Q000150:complications / Q000188:drug therapy*; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D014330:Tropical Medicine
D011804:Quinolines; D010303:Paromomycin
Prospettive terapeutiche con associazione chemio-antibiotica nelle affezioni batterico-protozoarie dell'intestino.